CanSino Biologics Risk Adjusted Performance


USD 13.26  0.37  2.71%   

CanSino Biologics risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for CanSino Biologics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
CanSino Biologics has current Risk Adjusted Performance of 0.2709.
(ER[a] - RFR) * STD[b])/STD[b] 
ER[a] = Expected return on investing in CanSino Biologics
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

CanSino Biologics Risk Adjusted Performance Peers Comparison

CanSino Risk Adjusted Performance Relative To Other Indicators

CanSino Biologics is number one stock in risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  155.49  of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for CanSino Biologics is roughly  155.49 
Compare CanSino Biologics to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas